The National survey on quality of anti-malaria medicines which was conducted in the six geo-political zones of the country, according to NAFDAC, was jointly undertaken by the National Malaria Elimination Programme of the Federal Ministry of Health and NAFDAC with the funding support by United States Pharmacopeial and USAID.
The agency said a highly elated Director-General of NAFDAC, Dr. Paul Orhii, said the introduction and deployment of new anti-counterfeiting cutting-edge technologies such as TRUSCAN, Mobile Authentication Services (MAS), Mini-laboratory and Deep Infra-red technology by NAFDAC under his watch were majorly responsible for the ground breaking success so far recorded in ensuring safe and good quality medicines in the country.
Dr. Orhii, the agency said in a report signed by Dr. Abubakar Jimoh, its Director of Special Duties, noted that the Agency has again done Nigeria and Africa proud with this remarkable achievement coming closely on the heels of the recent seizure of N5 billion worth of counterfeit drugs evacuated from five warehouses in Lagos and reiterated his determination to completely eradicate the menace of counterfeit drugs in the country very soon. The
Director-General thanked the USP, USAID, Federal Ministry of Health and other partner Agencies for their support towards the anti-counterfeiting war. Permanent Secretary of the Federal Ministry of Health, Mr. Linus Awute who chaired the survey report dissemination meeting in Abuja commended the United States Government for providing the needed fund for the survey while noting that the cheering news of the reduction in counterfeit drugs came at a time Nigeria has recorded progress in other public health issues.
Mr. Awute who was represented by the Ministry’s Director of Public Health, Dr. Bridget Okwuagwale reiterated Federal Government‘s determination to wipe out disease burden such as malaria, tuberculosis and HIV/AIDS.
The vice-president of USP, Dr. Patrick Lukulay observed that the success recorded by NAFDAC with the attainment of International Accreditation of her laboratory in Yaba, Lagos seven months ago laid a foundation for the current celebration of the results of the quality of medicine survey.
Dr. Lukulay said the various successes recorded by USP in her partnership with NAFDAC and other regulatory agencies in Nigeria within 4years surpassed other USP interventions for the past 10years in other African Countries.
It would be recalled that a survey of the quality of anti-malaria in Sub-sahara Africa undertaken by WHO in 2008 showed 64 percent incidence of fake anti-malaria in Nigeria and 13 other African countries. The assumption of office by Dr. Orhii as Director-General of NAFDAC led to reduction of the incidence of counterfeit drugs from 64% in 2008 to 19.6 percent in 2012 and later 3.6 percent in 2015.